TrialOphthalmology2016

A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema.

Henry E Wiley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.